This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data

This study has been completed.
Information provided by (Responsible Party):
Wei Shi, Guangdong General Hospital Identifier:
First received: December 29, 2011
Last updated: August 27, 2013
Last verified: August 2013
The pathological variants of IgA nephropathy identified by the Oxford classification may be related to the clinical data at presentation and follow-up, including proteinuria and renal function. This study is aimed to identify the potential relationship between pathological variants and clinical data in IgA nephropathy.

IgA Nephropathy

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: An Observational Study of the Relationship Between Pathological Variants and Clinical Data at Presentation and Follow-up in IgA Nephropathy

Resource links provided by NLM:

Further study details as provided by Wei Shi, Guangdong General Hospital:

Primary Outcome Measures:
  • glomerular filtration rate decline or end-stage renal disease or doubling of serum creatinine [ Time Frame: after the biopsy ]

Enrollment: 603
Study Start Date: September 2011
Study Completion Date: August 2013
Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
The population from which the cohort will be selected is these who have received renal biopsy in Guangdong General Hospital

Inclusion Criteria:

  • biopsy-proven IgA nephropathy;

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01502579

China, Guangdong
Guangdong General Hospital
Guangzhou, Guangdong, China, 510080
Sponsors and Collaborators
Guangdong General Hospital
Principal Investigator: Wei Shi, MD,PhD Guangdong General Hospital
  More Information

Responsible Party: Wei Shi, Professor, Guangdong General Hospital Identifier: NCT01502579     History of Changes
Other Study ID Numbers: GGH201106
Study First Received: December 29, 2011
Last Updated: August 27, 2013

Keywords provided by Wei Shi, Guangdong General Hospital:
IgA nephropathy

Additional relevant MeSH terms:
Kidney Diseases
Glomerulonephritis, IGA
Urologic Diseases
Autoimmune Diseases
Immune System Diseases processed this record on September 21, 2017